• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性阻塞性肺疾病急性加重的管理与预防:一篇前沿综述

Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review.

作者信息

Hurst John R, Wedzicha Jadwiga A

机构信息

Academic Unit of Respiratory Medicine, Royal Free Campus, UCL Medical School, London, UK.

出版信息

BMC Med. 2009 Aug 7;7:40. doi: 10.1186/1741-7015-7-40.

DOI:10.1186/1741-7015-7-40
PMID:19664218
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2734841/
Abstract

Exacerbations of chronic obstructive pulmonary disease (COPD) are important events in the natural history of this prevalent and devastating condition. This review provides a concise, state of the art summary on prevention and management of exacerbations. Considerable new data underpins evidence in support of many preventative interventions, pharmacological and non-pharmacological, that are now available. Challenges remain in developing new approaches, and delivering those that already exist to the right patient at the right time. Management of an exacerbation remains stepwise according to clinical severity, but there is now additional focus on addressing comorbidities and taking the opportunity at acute events to optimise preventative strategies for the future. Ultimately, exacerbations are heterogeneous events in a heterogeneous disease, and an individualised approach is paramount.

摘要

慢性阻塞性肺疾病(COPD)急性加重是这种常见且具有破坏性疾病自然史中的重要事件。本综述对急性加重的预防和管理进行了简洁的、最新的总结。大量新数据为许多现有的预防干预措施(包括药物和非药物措施)提供了证据支持。在开发新方法以及在正确的时间将现有方法应用于合适的患者方面,挑战依然存在。急性加重的管理仍根据临床严重程度逐步进行,但现在额外关注合并症的处理,并利用急性事件的机会优化未来的预防策略。最终,急性加重在这种异质性疾病中是异质性事件,个体化方法至关重要。

相似文献

1
Management and prevention of chronic obstructive pulmonary disease exacerbations: a state of the art review.慢性阻塞性肺疾病急性加重的管理与预防:一篇前沿综述
BMC Med. 2009 Aug 7;7:40. doi: 10.1186/1741-7015-7-40.
2
Tailored or adapted interventions for adults with chronic obstructive pulmonary disease and at least one other long-term condition: a mixed methods review.针对患有慢性阻塞性肺疾病和至少一种其他长期疾病的成年人的定制或改编干预措施:一项混合方法综述。
Cochrane Database Syst Rev. 2021 Jul 26;7(7):CD013384. doi: 10.1002/14651858.CD013384.pub2.
3
COPD exacerbations: management and hospital discharge.慢性阻塞性肺疾病急性加重:管理和出院。
Pulmonology. 2018 Nov-Dec;24(6):345-350. doi: 10.1016/j.pulmoe.2018.06.006. Epub 2018 Jul 23.
4
COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update.COPD-X 澳大利亚和新西兰慢性阻塞性肺疾病诊断和管理指南:2017 年更新版。
Med J Aust. 2017 Nov 20;207(10):436-442. doi: 10.5694/mja17.00686.
5
Unmet needs in the management of exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重管理中的未满足需求。
Intern Emerg Med. 2021 Apr;16(3):559-569. doi: 10.1007/s11739-020-02612-9. Epub 2021 Feb 22.
6
What happens between first symptoms and first acute exacerbation of COPD - observational study of routine data and patient survey.COPD 首次症状与首次急性加重之间的情况 - 常规数据和患者调查的观察性研究。
Health Soc Care Deliv Res. 2024 Oct;12(43):1-80. doi: 10.3310/CGTR6370.
7
Guideline for the management of chronic obstructive pulmonary disease--2011 update.慢性阻塞性肺疾病管理指南——2011 年更新版。
S Afr Med J. 2011 Jan;101(1 Pt 2):63-73.
8
Effect of an action plan with ongoing support by a case manager on exacerbation-related outcome in patients with COPD: a multicentre randomised controlled trial.行动方案联合个案经理持续支持对 COPD 患者加重相关结局的影响:一项多中心随机对照试验。
Thorax. 2011 Nov;66(11):977-84. doi: 10.1136/thoraxjnl-2011-200071. Epub 2011 Jul 23.
9
Digital interventions for the management of chronic obstructive pulmonary disease.数字干预措施在慢性阻塞性肺疾病管理中的应用。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD013246. doi: 10.1002/14651858.CD013246.pub2.
10
Exacerbation in patients with stable COPD in China: analysis of a prospective, 52-week, nationwide, observational cohort study (REAL).中国稳定期 COPD 患者的恶化:一项前瞻性、52 周、全国性、观察性队列研究(REAL)的分析。
Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231167353. doi: 10.1177/17534666231167353.

引用本文的文献

1
Implementation of an algorithm for predicting exacerbations in telemonitoring: A multimethod study of patients' and clinicians' experiences.远程监测中预测病情加重算法的实施:一项关于患者和临床医生体验的多方法研究
Int J Nurs Stud Adv. 2024 Oct 22;7:100257. doi: 10.1016/j.ijnsa.2024.100257. eCollection 2024 Dec.
2
Clinical implementation of an algorithm for predicting exacerbations in patients with COPD in telemonitoring: a study protocol for a single-blinded randomized controlled trial.在远程监测中应用预测 COPD 患者恶化的算法的临床实施:一项单盲随机对照试验的研究方案。
Trials. 2022 Apr 26;23(1):356. doi: 10.1186/s13063-022-06292-y.
3

本文引用的文献

1
Glucocorticoid resistance in inflammatory diseases.炎症性疾病中的糖皮质激素抵抗
Lancet. 2009 May 30;373(9678):1905-17. doi: 10.1016/S0140-6736(09)60326-3.
2
Pulmonary rehabilitation for management of chronic obstructive pulmonary disease.慢性阻塞性肺疾病管理中的肺康复治疗
N Engl J Med. 2009 Mar 26;360(13):1329-35. doi: 10.1056/NEJMct0804632.
3
Does early pulmonary rehabilitation reduce acute health-care utilization in COPD patients admitted with an exacerbation? A randomized controlled study.早期肺康复能否降低慢性阻塞性肺疾病(COPD)急性加重期住院患者的急性医疗资源利用?一项随机对照研究。
Efficacy and safety of Maxing Shigan Decoction in the treatment of chronic obstructive pulmonary disease: A protocol for a systematic review and meta-analysis.
麻杏石甘汤治疗慢性阻塞性肺疾病的疗效与安全性:一项系统评价与Meta分析方案
Medicine (Baltimore). 2020 Dec 4;99(49):e23284. doi: 10.1097/MD.0000000000023284.
4
Guiding Principles for the Use of Nebulized Long-Acting Beta2-Agonists in Patients with COPD: An Expert Panel Consensus.慢性阻塞性肺疾病患者使用雾化长效β2受体激动剂的指导原则:专家小组共识
Chronic Obstr Pulm Dis. 2016 Nov 15;4(1):7-20. doi: 10.15326/jcopdf.4.1.2016.0141.
5
MAP3K19 Is Overexpressed in COPD and Is a Central Mediator of Cigarette Smoke-Induced Pulmonary Inflammation and Lower Airway Destruction.丝裂原活化蛋白激酶激酶激酶19在慢性阻塞性肺疾病中过表达,是香烟烟雾诱导的肺部炎症和下气道破坏的核心介质。
PLoS One. 2016 Dec 9;11(12):e0167169. doi: 10.1371/journal.pone.0167169. eCollection 2016.
6
Severe COPD Exacerbation Risk and Long-Acting Bronchodilator Treatments: Comparison of Three Observational Data Analysis Methods.重度慢性阻塞性肺疾病急性加重风险与长效支气管扩张剂治疗:三种观察性数据分析方法的比较
Drugs Real World Outcomes. 2015 Jun;2(2):163-175. doi: 10.1007/s40801-015-0025-6.
7
Association of serum magnesium levels with frequency of acute exacerbations in chronic obstructive pulmonary disease: a prospective study.血清镁水平与慢性阻塞性肺疾病急性加重频率的关联:一项前瞻性研究。
Pulm Med. 2014;2014:329476. doi: 10.1155/2014/329476. Epub 2014 Nov 18.
8
Characterization of the inflammatory response to inhaled lipopolysaccharide in mild to moderate chronic obstructive pulmonary disease.轻度至中度慢性阻塞性肺疾病中对吸入脂多糖炎症反应的特征
Br J Clin Pharmacol. 2015 May;79(5):767-76. doi: 10.1111/bcp.12546.
9
Study of drug utilization pattern for acute exacerbation of chronic obstructive pulmonary disease in patients attending a government hospital in kerala, India.印度喀拉拉邦一家政府医院慢性阻塞性肺疾病急性加重患者的药物使用模式研究。
J Family Med Prim Care. 2014 Jul;3(3):250-4. doi: 10.4103/2249-4863.141622.
10
Impact of a functional polymorphism in the PAR-1 gene promoter in COPD and COPD exacerbations.PAR-1 基因启动子功能多态性在 COPD 及 COPD 加重中的作用。
Am J Physiol Lung Cell Mol Physiol. 2014 Aug 15;307(4):L311-6. doi: 10.1152/ajplung.00128.2014. Epub 2014 Jun 27.
Respirology. 2009 Mar;14(2):230-8. doi: 10.1111/j.1440-1843.2008.01418.x.
4
Asthma.哮喘
N Engl J Med. 2009 Mar 5;360(10):1002-14. doi: 10.1056/NEJMra0804579.
5
Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial.稳定期高碳酸血症慢性阻塞性肺疾病患者夜间无创经鼻通气:一项随机对照试验。
Thorax. 2009 Jul;64(7):561-6. doi: 10.1136/thx.2008.108274. Epub 2009 Feb 12.
6
Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis.吸入药物减少慢性阻塞性肺疾病患者急性加重:一项网状Meta分析。
BMC Med. 2009 Jan 14;7:2. doi: 10.1186/1741-7015-7-2.
7
Temporal clustering of exacerbations in chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重的时间聚集性。
Am J Respir Crit Care Med. 2009 Mar 1;179(5):369-74. doi: 10.1164/rccm.200807-1067OC. Epub 2008 Dec 12.
8
Infection in the pathogenesis and course of chronic obstructive pulmonary disease.感染在慢性阻塞性肺疾病的发病机制及病程中的作用
N Engl J Med. 2008 Nov 27;359(22):2355-65. doi: 10.1056/NEJMra0800353.
9
Where is the supporting evidence for treating mild to moderate chronic obstructive pulmonary disease exacerbations with antibiotics? A systematic review.使用抗生素治疗轻至中度慢性阻塞性肺疾病加重期的支持证据在哪里?一项系统评价。
BMC Med. 2008 Oct 10;6:28. doi: 10.1186/1741-7015-6-28.
10
A 4-year trial of tiotropium in chronic obstructive pulmonary disease.噻托溴铵用于慢性阻塞性肺疾病的4年试验。
N Engl J Med. 2008 Oct 9;359(15):1543-54. doi: 10.1056/NEJMoa0805800. Epub 2008 Oct 5.